Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock

This study examines the use of ECMO (extracorporeal membrane oxygenation) — a machine that takes over the work of the heart and lungs — in critically ill children with severe respiratory failure. ECMO is a last-resort life-support technology for children whose lungs or heart are failing despite all other treatments. The study looks at outcomes and investigates the optimal timing for starting ECMO therapy. By studying when ECMO is most beneficial and what patient characteristics predict success, researchers hope to create better guidelines that save more young lives. This is important because ECMO is resource-intensive and carries risks, so knowing exactly when and how to use it matters enormously. You may be eligible if: - You are a child (pediatric patient) with severe respiratory failure - You are being treated in an intensive care unit - Standard respiratory support has been insufficient You may NOT be eligible if: - There are underlying conditions that make ECMO contraindicated (e.g., terminal illness, severe brain damage) - Parental or guardian consent cannot be obtained - You are not a pediatric patient Talk to your doctor to see if this trial is right for you.